Skip to content
MarketScale
‹ Back to IndustriesSciences

7 Companies Bringing Innovation to NRF 2019

It’s possible that no group of companies benefits as much from NRF 2019 as those with space in the Innovation Lab. Designed to group start-ups together in an easy to navigate area, the Innovation Lab is a carefully curated group of businesses that the NRF believes have something significant to show off. MarketScale took a…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Geoff Short · Geoff Short Article
Share
7 Companies Bringing Innovation to NRF 2019

Key takeaways

01

It’s possible that no group of companies benefits as much from NRF 2019 as those with space in the Innovation Lab.

02

Designed to group start-ups together in an easy to navigate area, the Innovation Lab is a carefully curated group of businesses that the NRF believes have something significant to show off.

It’s possible that no group of companies benefits as much from NRF 2019 as those with space in the Innovation Lab. Designed to group start-ups together in an easy to navigate area, the Innovation Lab is a carefully curated group of businesses that the NRF believes have something significant to show off.

MarketScale took a private media tour of the area on the first day of NRF 2019 to see what stood out amongst these rising brands.

Perfitly: More and more, shoppers have turned to the internet to purchase products because of its convenience. In the clothing and fashion industry though, there are still some elements that simply cannot replicate the brick-and-mortar experience, mainly trying on items. Perfitly attempts to solve this issue through AR/VR visualization. Users create a digital avatar based on two simple photos of themselves. The avatar can be used on any clothing brand’s site that teams with this startup. The technology uses 240,000 data points to make the avatar and clothing sizes as accurate as possible and a spokesperson said their clients have seen a reduction in item returns from 28 percent to 10.

Tompkins Robotics: Another impact of the e-commerce world is the need for extremely efficient and precise distribution centers. Tompkins Robotics is automating this process with its team of mobile item sorting devices for warehouses. According to the company, four of the United States’ 10 largest retailers have already partnered signed on to use the ‘automated robotic sortation’ devices.

https://www.instagram.com/p/BsqMaAZlTNz/

Locix: Also innovating in warehouse processes is Locix. The company uses image and machine learning to collect data on distribution center operations so retailers can better streamline workflow. Tools like an indoor GPS and HD motion sensors provide business analytics in real time.

The company uses image and machine learning to collect data on distribution center operations so retailers can better streamline workflow.

IAM Robotics: As a solution to the warehouse labor shortage, IAM robotics seeks to keep businesses efficient by automating the fulfillment operations for retailers. At the Innovation Lab, the company was showcasing its item-sorting robot that can be used both in the warehouse and storefront. Robotic devices were a major theme at this year’s show and IAM was among the most impressive.

https://www.instagram.com/p/BsqL_OwlGaW/

Onfleet: This last mile delivery solutions company is essentially doing for shipping what Uber has done for personal travel. Through its web dashboard, retail professionals can assign shipments to specific drivers based on convenience and other factors like who is nearest by and update them with real time maps. By sending the right driver at the right time on the right route, retailers can save time and deliver to customers efficiently.

Narrativ: Founded in 2015, this CNBC Top 100 Startup to watch is connecting brands with the content created about them online. The company lets businesses bid for publishers to link and mention them in their articles. This way, brands can gain exposure without creating an advertising strategy and drive sales to their site. Narrativ is already profitable and aims to help retailers win back customers from Amazon.

Trendalytics: Retailers, especially clothiers, are always trying to stay on top of the latest trends. Often, they are chasing trends that have already peaked in popularity however, or do not know whether the trend will be sustained. Trendalytics looks at data like Google search volume to identify trends and uncover their staying power in real time. With this new insight, brands can re-word existing product names to gain better traction on online searches and increase their visibility overall.

More NRF 2019!

With the first day of NRF under his belt, MarketScale’s Chief Digital Editor Geoff Short joined the podcast to provide an update of what he has seen so far. He marveled at the advancements in facial recognition technology, talked about his favorite booth so far, and provided an update on whether or not he has eaten one of those famous New York hot dogs.

For the latest news, videos, and podcasts in the Retail Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @RetailMKSL

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

About the author

GS
Geoff Short

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Sciences Insights

Biopharma's $300 Billion Problem Is Driving the Biggest M&A Cycle in a Decade

Biopharma's $300 Billion Problem Is Driving the Biggest M&A Cycle in a Decade

The pharmaceutical industry is facing a significant challenge as over $300 billion in branded pharmaceutical revenue is set to lose patent protection by 2030. This revenue gap is driving the largest merger and acquisition cycle seen in a decade, with companies seeking external growth through acquisitions. This shift is impacting the entire life sciences supply chain, prompting strategic changes across the industry.

  • 01Over $300 billion in pharmaceutical revenue is at risk due to patent expirations by 2030.
  • 02Big Pharma is engaging in an aggressive cycle of mergers and acquisitions.
  • 03The acquisitions are reshaping the life sciences supply chain.

Jun 29, 2026

Quotient Sciences launches Phase I study of what it calls the first AI-formulated drug in the clinic

Quotient Sciences launches Phase I study of what it calls the first AI-formulated drug in the clinic

Quotient Sciences has initiated a Phase I clinical study at its UK facility for an oral solid dose formulation designed using artificial intelligence — what the company believes is the first AI-formulated drug to reach human clinical evaluation. The study, cleared by the UK's Medicines and Healthcare products Regulatory Agency, will assess safety and pharmacokinetics in healthy volunteers. The program, which used Intrepid Labs' machine learning algorithm, signals a broader shift in how contract drug development organizations are integrating AI across formulation and clinical workflows.

  • 01Quotient Sciences initiated a Phase I study of an AI-designed oral solid dose formulation at its UK facility following MHRA approval — the first such case the company believes has been reported.
  • 02The formulation was developed using Intrepid Labs' advanced machine learning algorithm in combination with Quotient Sciences' Translational Pharmaceutics platform.
  • 03The milestone is part of a broader CRDMO strategy to embed AI-enabled approaches across formulation development and clinical workflows, with implications for the wider contract pharma sector.

Jun 17, 2026

Quotient Sciences launches Phase I trial of what it calls the first AI-formulated drug to reach the clinic

Quotient Sciences launches Phase I trial of what it calls the first AI-formulated drug to reach the clinic

Quotient Sciences has initiated a Phase I clinical study of an oral solid dose formulation designed using AI, cleared by the UK's MHRA and conducted at the company's UK facility. The trial—built on machine learning algorithms from partner Intrepid Labs and Quotient's Translational Pharmaceutics platform—aims to validate AI as a direct contributor to formulation design rather than just an upstream analytical tool. Benchling characterizes the broader moment as biotech entering a "builder phase," in which leading organizations embed AI capability at the bench level rather than running isolated pilots.

  • 01Quotient Sciences has dosed healthy volunteers in a Phase I study it describes as the first clinical evaluation of an AI-designed oral formulation, following approval from the UK's MHRA.
  • 02The formulation was developed using advanced machine learning algorithms from Intrepid Labs, integrated with Quotient Sciences' Translational Pharmaceutics platform.
  • 03Benchling identifies a sector-wide shift toward embedding AI capability directly at the bench, moving beyond isolated pilots to structural adoption across biotech R&D.

Jun 17, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

GS
Geoff Short

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512